Clinical Trial

A Clinical Trial Comparing 2x/Day for 30-minutes Use of the Emanate Perio PODS Post-SRP to a Control Group Post-SRP.

Recruiting
View on ClinicalTrials.gov →
Summary
The goal of this clinical trial is to compare safety and to see if individuals with generalized stage III periodontitis that are given a periodontal hydrogel dressing on a wound healing after plaque and tartar have been removed from teeth have greater healing than individuals who are given no treatment after.
Protocol Amendment History 2 changes
notable Enrollment reduced: 111 -> 72 participants 2026-04-28
minor Trial arms changed: 3 -> 2 2026-04-28
Trial Details
NCT Number NCT06914596
Lead Sponsor McGuire Institute
Collaborators: Emanate Biomedical Inc.
Conditions Periodontitis (Stage 3)
Enrollment 72 participants
Start Date 2026-02-19
Primary Completion 2026-12-30 (estimated)
Study Completion 2027-01-30 (estimated)
Updated on ClinicalTrials.gov 2026-06-24